Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF-III renal cysts: a multicenter study

T. Pitra, K. Pivovarcikova, R. Tupy, R. Alaghehbandan, T. Barakova, I. Travnicek, K. Prochazkova, T. Klatte, P. Chlosta, O. Hes, M. Hora,

. 2018 ; 36 (6) : 905-911. [pub] 20180130

Language English Country Germany

Document type Journal Article, Multicenter Study

INTRODUCTION: CT imaging is the standard examination for renal cystic lesions and defines the Bosniak category, which dictates further management. Given that Bosniak II/IIF/III renal cystic lesions can potentially harbor renal cell carcinoma (RCC), additional diagnostic modalities may be required in management decision making. AIM: To determine the value of additional magnetic resonance imaging in CT-defined Bosniak IIF-III renal cystic lesions. MATERIALS AND METHODS: This a multicenter retrospective study of 46 consecutive patients, diagnosed with cystic renal lesions between 2009 and 2016. The inclusion criteria were: (1) cystic renal lesion classified as Bosniak IIF-III on CT, (2) a subsequent MRI examination, and (3) documented outcome via surgery for cystic renal mass or follow-up. RESULTS: 46 patients (35 males, 11 females) were included. The mean size of the cystic lesion was 3.92 cm (0.7-10 cm). According to the CT findings, Bosniak IIF and III were found in 12 (26.1%) and 34 (73.9%) cases. Reclassification of Bosniak category was done after MRI examination in 31 cases (67.4%). An upgrade rate of 58.7% (27 cases) to a higher category was made, while the downgrade rate to a lower category was achieved in 4 cases (8.7%). As a result, significant therapeutic management change was made in 12/31 patients (38.7%), of whom 8 underwent subsequent surgery. CONCLUSION: MRI study may reduce the use of Bosniak IIF category (in comparison with CT), which has a direct impact on therapeutic management (surgery vs. surveillance) in a significant proportion of patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012879
003      
CZ-PrNML
005      
20190408082011.0
007      
ta
008      
190405s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00345-018-2176-z $2 doi
035    __
$a (PubMed)29383479
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Pitra, Tomas $u Department of Urology, Medical Faculty, Charles University, Charles University Hospital Plzen, E. Beneše 13, 305 99, Plzeň, Czech Republic. pitrat@fnplzen.cz.
245    10
$a Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF-III renal cysts: a multicenter study / $c T. Pitra, K. Pivovarcikova, R. Tupy, R. Alaghehbandan, T. Barakova, I. Travnicek, K. Prochazkova, T. Klatte, P. Chlosta, O. Hes, M. Hora,
520    9_
$a INTRODUCTION: CT imaging is the standard examination for renal cystic lesions and defines the Bosniak category, which dictates further management. Given that Bosniak II/IIF/III renal cystic lesions can potentially harbor renal cell carcinoma (RCC), additional diagnostic modalities may be required in management decision making. AIM: To determine the value of additional magnetic resonance imaging in CT-defined Bosniak IIF-III renal cystic lesions. MATERIALS AND METHODS: This a multicenter retrospective study of 46 consecutive patients, diagnosed with cystic renal lesions between 2009 and 2016. The inclusion criteria were: (1) cystic renal lesion classified as Bosniak IIF-III on CT, (2) a subsequent MRI examination, and (3) documented outcome via surgery for cystic renal mass or follow-up. RESULTS: 46 patients (35 males, 11 females) were included. The mean size of the cystic lesion was 3.92 cm (0.7-10 cm). According to the CT findings, Bosniak IIF and III were found in 12 (26.1%) and 34 (73.9%) cases. Reclassification of Bosniak category was done after MRI examination in 31 cases (67.4%). An upgrade rate of 58.7% (27 cases) to a higher category was made, while the downgrade rate to a lower category was achieved in 4 cases (8.7%). As a result, significant therapeutic management change was made in 12/31 patients (38.7%), of whom 8 underwent subsequent surgery. CONCLUSION: MRI study may reduce the use of Bosniak IIF category (in comparison with CT), which has a direct impact on therapeutic management (surgery vs. surveillance) in a significant proportion of patients.
650    _2
$a cysty $7 D003560
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a cystická onemocnění ledvin $x diagnostické zobrazování $x patologie $7 D052177
650    _2
$a nádory ledvin $7 D007680
650    12
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a počítačová rentgenová tomografie $7 D014057
651    _2
$a Rakousko $7 D001317
651    _2
$a Česká republika $7 D018153
651    _2
$a Polsko $7 D011044
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Pivovarcikova, Kristyna $u Department of Pathology, Medical Faculty, Charles University, Charles University Hospital Plzen, Plzeň, Czech Republic.
700    1_
$a Tupy, Radek $u Department of Radiology, Medical Faculty, Charles University, Charles University Hospital Plzen, Plzeň, Czech Republic.
700    1_
$a Alaghehbandan, Reza $u Department of Pathology, Faculty of Medicine, University of British Columbia, Royal Columbian Hospital, Vancouver, BC, Canada.
700    1_
$a Barakova, Tana $u Department of Radiology, Medical Faculty, Charles University, Charles University Hospital Plzen, Plzeň, Czech Republic.
700    1_
$a Travnicek, Ivan $u Department of Urology, Medical Faculty, Charles University, Charles University Hospital Plzen, E. Beneše 13, 305 99, Plzeň, Czech Republic.
700    1_
$a Prochazkova, Kristyna $u Department of Urology, Medical Faculty, Charles University, Charles University Hospital Plzen, E. Beneše 13, 305 99, Plzeň, Czech Republic.
700    1_
$a Klatte, Tobias $u Department of Urology, Medical University of Vienna, Vienna, Austria.
700    1_
$a Chlosta, Piotr $u Department of Urology, Jagiellonian University Medical College, Kraków, Poland.
700    1_
$a Hes, Ondrej $u Department of Pathology, Medical Faculty, Charles University, Charles University Hospital Plzen, Plzeň, Czech Republic.
700    1_
$a Hora, Milan $u Department of Urology, Medical Faculty, Charles University, Charles University Hospital Plzen, E. Beneše 13, 305 99, Plzeň, Czech Republic.
773    0_
$w MED00004739 $t World journal of urology $x 1433-8726 $g Roč. 36, č. 6 (2018), s. 905-911
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29383479 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190408082024 $b ABA008
999    __
$a ok $b bmc $g 1392189 $s 1051184
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 36 $c 6 $d 905-911 $e 20180130 $i 1433-8726 $m World journal of urology $n World J Urol $x MED00004739
LZP    __
$a Pubmed-20190405

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...